{"content":"<li class=\"n-box-item date-title\" data-end=\"1353733199\" data-start=\"1353646800\" data-txt=\"Wednesday, December 18, 2019\">Friday, November 23, 2012</li><li class=\"n-box-item sa-box-item\" data-id=\"681481\" data-ts=\"1353697307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681481\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molycorp (MCP +19%) finished the day sharply higher, albeit in a light trading session. In...</a></h4><p>Molycorp (MCP <font color=\"green\">+19%</font>) finished the day sharply higher, albeit in a light trading session. In addition to earlier reports of <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/680911\">insider buying</a>, another catalyst for the move may have come from a report that the Chinese government has <a target=\"_blank\" href=\"http://www.mineweb.com/mineweb/content/en/mineweb-industrial-metals-minerals-old?oid=163303&amp;sn=Detail\">earmarked a special fund</a> from its budget to streamline and improve its domestic rare earths industry in an effort to stem the bleeding from falling prices plunging corporate profits. The fund will be used to help companies upgrade their technology and promote \u201chealthy and orderly development.\u201d</p><div class=\"tiny-share-widget\" data-id=\"681481\" data-linked=\"Molycorp (MCP +19%) finished the day sharply higher, albeit in a light trading session. In...\" data-tweet=\"Molycorp (MCP +19%) finished the day sharply higher, albeit in a light trading session. In addition to earlier reports of insider buying, another catalyst for the move may have come from a report that the Chinese government has earmarked a special fund ... https://seekingalpha.com/news/681481?source=tweet\" data-url=\"https://seekingalpha.com/news/681481\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681451\" data-ts=\"1353694917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAPP\" target=\"_blank\">MAPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of MAP Pharmaceuticals (NASDAQ:MAPP) soared today, finishing up over +20% after the...</a></h4>Shares of MAP Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MAPP' title='MAP Pharmaceuticals, Inc.'>MAPP</a>) soared today, finishing up over <font color=\"green\">+20%</font> after the company announced that the <a target=\"_blank\" target=\"_blank\" href=\"https://seekingalpha.com/currents/post/680281\">FDA accepted</a> its Levadex resubmission with a six-month review.<div class=\"tiny-share-widget\" data-id=\"681451\" data-linked=\"Shares of MAP Pharmaceuticals (NASDAQ:MAPP) soared today, finishing up over +20% after the...\" data-tweet=\"$MAPP - Shares of MAP Pharmaceuticals (NASDAQ:MAPP) soared today, finishing up over +20% after the company announced that the FDA accepted its Levadex resubmission with a six-month review. https://seekingalpha.com/news/681451?source=tweet\" data-url=\"https://seekingalpha.com/news/681451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681361\" data-ts=\"1353692728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCCL\" target=\"_blank\">CCCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: CCCL +42%. MAPP +21%. OTC:BGMD +21%. MCP +18%. INUV +16%. FIZZ +15%....</a></h4><b>Midday top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/CCCL' title='China Ceramics Co., Ltd.'>CCCL</a> <font color=\"green\">+42%</font>. <a href='https://seekingalpha.com/symbol/MAPP' title='MAP Pharmaceuticals, Inc.'>MAPP</a> <font color=\"green\">+21%</font>. <a href='https://seekingalpha.com/symbol/BGMD' title='BG Medicine, Inc.'>OTC:BGMD</a> <font color=\"green\">+21%</font>. MCP <font color=\"green\">+18%</font>. <a href='https://seekingalpha.com/symbol/INUV' title='Inuvo, Inc'>INUV</a> <font color=\"green\">+16%</font>. <a href='https://seekingalpha.com/symbol/FIZZ' title='National Beverage Corp.'>FIZZ</a> <font color=\"green\">+15%</font>. <a href='https://seekingalpha.com/symbol/ROSG-OLD' title='Rosetta Genomics Ltd.'>ROSG-OLD</a> <font color=\"green\">+14%</font>. <a href='https://seekingalpha.com/symbol/DAC' title='Danaos Corporation'>DAC</a> <font color=\"green\">+13%</font>. RIMM <font color=\"green\">+13%</font>. <a href='https://seekingalpha.com/symbol/RIC' title='Richmont Mines, Inc'>RIC</a> <font color=\"green\">+12%</font>.  <br /><b>Top 10 Losers:</b> <a href='https://seekingalpha.com/symbol/KITD' title='KIT digital, Inc.'>OTC:KITD</a> <font color=\"red\">-64%</font>. <a href='https://seekingalpha.com/symbol/PTGI' title='PTGi Holding, Inc.'>PTGI</a> <font color=\"red\">-17%</font>. <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color=\"red\">-12%</font>. <a href='https://seekingalpha.com/symbol/HDSN' title='Hudson Technologies, Inc.'>HDSN</a> <font color=\"red\">-9%</font>. <a href='https://seekingalpha.com/symbol/TELK' title='Telik, Inc.'>OTCQB:TELK</a> <font color=\"red\">-9%</font>. <a href='https://seekingalpha.com/symbol/SAB-OLD' title='Grupo Casa Saba, S.A. De C.V.'>SAB-OLD</a> <font color=\"red\">-8%</font>. HRT <font color=\"red\">-8%</font>. <a href='https://seekingalpha.com/symbol/NFEC' title='NF Energy Saving Corp.'>NFEC</a> <font color=\"red\">-8%</font>. THQI <font color=\"red\">-7%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color=\"red\">-7%</font>.<div class=\"tiny-share-widget\" data-id=\"681361\" data-linked=\"Midday top 10 gainers: CCCL +42%. MAPP +21%. OTC:BGMD +21%. MCP +18%. INUV +16%. FIZZ +15%....\" data-tweet=\"$CCCL $CCCL $MAPP - Midday top 10 gainers: CCCL +42%. MAPP +21%. OTC:BGMD +21%. MCP +18%. INUV +16%. FIZZ +15%. ROSG-OLD +14%. DAC +13%. RIMM +13%. RIC +12%. Top 10 Losers: OTC:KITD -64%. PTGI -17%. SGOC -12%. HDSN -9%. OTCQB:TELK -9%. SAB-OLD -8%. HRT ... https://seekingalpha.com/news/681361?source=tweet\" data-url=\"https://seekingalpha.com/news/681361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681341\" data-ts=\"1353692536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITMN\" target=\"_blank\">ITMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681341\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of InterMune (ITMN +7.8%) moves higher today on no significant news to speak of. One...</a></h4><p>Shares of InterMune (<a href=\"https://seekingalpha.com/symbol/ITMN\" title=\"InterMune, Inc.\">ITMN</a> <font color=\"green\">+7.8%</font>) moves higher today on no significant news to speak of. One positive catalyst could be from <a target=\"_blank\" href=\"https://seekingalpha.com/article/1023351-can-intermune-sustain-positive-momentum\">an article</a> posted in Seeking Alpha late Wednesday rating the stock a Buy. The gist of the article is that, despite the risk of company being dependent on a single product - Esbriet - for growth, the company has thrown all its marketing resources behind its launch and expects it to yield a high payout for the effort.</p><div class=\"tiny-share-widget\" data-id=\"681341\" data-linked=\"Shares of InterMune (ITMN +7.8%) moves higher today on no significant news to speak of. One...\" data-tweet=\"$ITMN - Shares of InterMune (ITMN +7.8%) moves higher today on no significant news to speak of. One positive catalyst could be from an article posted in Seeking Alpha late Wednesday rating the stock a Buy. The gist of the article is that, despite the ri... https://seekingalpha.com/news/681341?source=tweet\" data-url=\"https://seekingalpha.com/news/681341\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681271\" data-ts=\"1353690852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MUX\" target=\"_blank\">MUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681271\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McEwen Mining (MUX +6.2%) says it may sell its Los Azules copper project to free up cash for...</a></h4><p>McEwen Mining (<a href=\"https://seekingalpha.com/symbol/MUX\" title=\"McEwen Mining Inc.\">MUX</a> <font color=\"green\">+6.2%</font>) says it <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-11-22/mcewen-shops-copper-mine-to-focus-on-gold.html\">may sell its Los Azules copper project</a> to free up cash for precious metals exploration projects in Argentina, Mexico and the U.S. Los Azules is worth ~$535M, based partly on the deposit\u2019s 15B lbs. of copper resources, but could cost almost five times that to develop, and a junior miner isn't likely to come up with the necessary $2.5B.</p><div class=\"tiny-share-widget\" data-id=\"681271\" data-linked=\"McEwen Mining (MUX +6.2%) says it may sell its Los Azules copper project to free up cash for...\" data-tweet=\"$MUX - McEwen Mining (MUX +6.2%) says it may sell its Los Azules copper project to free up cash for precious metals exploration projects in Argentina, Mexico and the U.S. Los Azules is worth ~$535M, based partly on the deposit\u2019s 15B lbs. of copper resou... https://seekingalpha.com/news/681271?source=tweet\" data-url=\"https://seekingalpha.com/news/681271\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681231\" data-ts=\"1353689434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STJ\" target=\"_blank\">STJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of St. Jude Medical (STJ +3%) claw back a bit of their 12% pummeling taken on Wednesday...</a></h4><p>Shares of St. Jude Medical (<a href=\"https://seekingalpha.com/symbol/STJ\" title=\"St. Jude Medical, Inc.\">STJ</a> <font color=\"green\">+3%</font>) claw back a bit of their 12% pummeling taken on Wednesday following the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/678261\">FDA's release</a>  of a report citing serious flaws in <a href=\"https://seekingalpha.com/symbol/STJ\" title=\"St. Jude Medical, Inc.\">STJ</a>'s oversight of Durata. BofA Merrill Lynch notes that the report found no new safety issues and the <a target=\"_blank\" href=\"http://www.theflyonthewall.com/permalinks/entry.php/SVU;STJid1744538/SVU;STJ-Stocks-with-implied-volatility-movement-SVU-STJ\">probability of a recall</a> stands well below 50%, which is already priced into the stock. It  reiterates a Buy with a potential downside to $24 and an upside peaking around $40.</p><div class=\"tiny-share-widget\" data-id=\"681231\" data-linked=\"Shares of St. Jude Medical (STJ +3%) claw back a bit of their 12% pummeling taken on Wednesday...\" data-tweet=\"$STJ - Shares of St. Jude Medical (STJ +3%) claw back a bit of their 12% pummeling taken on Wednesday following the FDA&#39;s release of a report citing serious flaws in STJ&#39;s oversight of Durata. BofA Merrill Lynch notes that the report found no new safety... https://seekingalpha.com/news/681231?source=tweet\" data-url=\"https://seekingalpha.com/news/681231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681221\" data-ts=\"1353688923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla Motors (TSLA -1.6%) shares are lower despite advice from Maxim Group&#39;s Aaron Chew for a...</a></h4><p>Tesla Motors (<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a> <font color=\"red\">-1.6%</font>) shares are lower despite advice from Maxim Group's Aaron Chew for a <a target=\"_blank\" href=\"http://blogs.barrons.com/techtraderdaily/2012/11/23/tsla-buying-opp-on-price-hike-concerns-says-maxim\">potential buying opportunity</a> on hints the electric car maker may be <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/679261\">planning a price hike</a> on its Model S sedan. Investors may view a potential price hike as a sign of slowing demand or trouble reaching production goals, but Chew prefers to see some silver linings.</p><div class=\"tiny-share-widget\" data-id=\"681221\" data-linked=\"Tesla Motors (TSLA -1.6%) shares are lower despite advice from Maxim Group&#39;s Aaron Chew for a...\" data-tweet=\"$TSLA - Tesla Motors (TSLA -1.6%) shares are lower despite advice from Maxim Group&#39;s Aaron Chew for a potential buying opportunity on hints the electric car maker may be planning a price hike on its Model S sedan. Investors may view a potential price hi... https://seekingalpha.com/news/681221?source=tweet\" data-url=\"https://seekingalpha.com/news/681221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681201\" data-ts=\"1353687718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAYRY\" target=\"_blank\">BAYRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A new and potential blockbuster drug from Bayer (OTCPK:BAYRY +4%), Regorafenib, could...</a></h4><p>A new and <a target=\"_blank\" href=\"http://www.foxbusiness.com/news/2012/11/22/bayer-drug-improves-survival-rates-for-stomach-tumors-study/\">potential blockbuster</a> drug from Bayer (<a href=\"https://seekingalpha.com/symbol/BAYRY\" title=\"Bayer A.G. ADR\">OTCPK:BAYRY</a> <font color=\"green\">+4%</font>), Regorafenib, could significantly increase the survival prospects of people with gastrointestinal cancer, according to new research published in U.K. medical journal <em>The Lancet</em>. The study also showed survival rates for patients with metastatic bowel cancer improved by taking the drug as well, though not as significantly. Bayer has tagged Regorafenib as one of its most significant new pipeline products.</p><div class=\"tiny-share-widget\" data-id=\"681201\" data-linked=\"A new and potential blockbuster drug from Bayer (OTCPK:BAYRY +4%), Regorafenib, could...\" data-tweet=\"$BAYRY - A new and potential blockbuster drug from Bayer (OTCPK:BAYRY +4%), Regorafenib, could significantly increase the survival prospects of people with gastrointestinal cancer, according to new research published in U.K. medical journal The Lancet. ... https://seekingalpha.com/news/681201?source=tweet\" data-url=\"https://seekingalpha.com/news/681201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681121\" data-ts=\"1353685787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681121\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RIMM&#39;s (RIMM +13%) rise follows yesterday&#39;s 17% surge in Toronto trading, which was sparked by a...</a></h4><p>RIMM's (RIMM <font color=\"green\">+13%</font>) rise follows yesterday's 17% surge in Toronto trading, which was sparked by a <a target=\"_blank\" href=\"http://business.financialpost.com/2012/11/22/rim-soars-on-bb10-optimism/\">target price bump</a> from the first analyst to raise his rating on RIM shares. Kris Thompson cites \u201cpositive sentiment building in the industry\" ahead of the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/680761\">BB10 Blackberry update</a>. On Tuesday, Jefferies' Peter Misek, a longtime RIM critic, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/675731\">raised his rating</a> and price target on the stock.</p><div class=\"tiny-share-widget\" data-id=\"681121\" data-linked=\"RIMM&#39;s (RIMM +13%) rise follows yesterday&#39;s 17% surge in Toronto trading, which was sparked by a...\" data-tweet=\"$BB - RIMM&#39;s (RIMM +13%) rise follows yesterday&#39;s 17% surge in Toronto trading, which was sparked by a target price bump from the first analyst to raise his rating on RIM shares. Kris Thompson cites \u201cpositive sentiment building in the industry&quot; ahead of... https://seekingalpha.com/news/681121?source=tweet\" data-url=\"https://seekingalpha.com/news/681121\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681111\" data-ts=\"1353684934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAX\" target=\"_blank\">BAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681111\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baxter International (BAX +1.4%) is in talks on a deal to buy Swedish medical-equipment maker...</a></h4>Baxter International (<a href='https://seekingalpha.com/symbol/BAX' title='Baxter International Inc'>BAX</a> <font color=\"green\">+1.4%</font>) is <a target=\"_blank\" href=\"http://online.wsj.com/article/SB10001424127887324851704578136980172263100.html\" target=\"_blank\">in talks</a> on a deal to buy Swedish medical-equipment maker Gambro for roughly $4B. Though still in its early stages, the companies are aiming to complete a deal within the next two to three weeks.<div class=\"tiny-share-widget\" data-id=\"681111\" data-linked=\"Baxter International (BAX +1.4%) is in talks on a deal to buy Swedish medical-equipment maker...\" data-tweet=\"$BAX - Baxter International (BAX +1.4%) is in talks on a deal to buy Swedish medical-equipment maker Gambro for roughly $4B. Though still in its early stages, the companies are aiming to complete a deal within the next two to three weeks. https://seekingalpha.com/news/681111?source=tweet\" data-url=\"https://seekingalpha.com/news/681111\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681081\" data-ts=\"1353684203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROSG-OLD\" target=\"_blank\">ROSG-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosetta Genomics (ROSG-OLD +9.7%) spikes as New York grants final approval for its miRview lung...</a></h4><p>Rosetta Genomics (<a href=\"https://seekingalpha.com/symbol/ROSG-OLD\" title=\"Rosetta Genomics Ltd.\">ROSG-OLD</a> <font color=\"green\">+9.7%</font>) spikes as New York grants final approval for its <a target=\"_blank\" href=\"http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&amp;r=1&amp;p=1&amp;f=G&amp;l=50&amp;d=PG01&amp;S1=%28%22rosetta+genomics%22.AS.%29&amp;OS=an/%22rosetta+genomics%22&amp;RS=AN/%22rosetta+genomics%22\">miRview lung assay</a> that can accurately differentiate between the four main subtypes of lung cancer using small amounts of tumor cells. With this approval, ROSG can continue to offer miRviev in all 50 U.S. states; NY is the only state that requires an independent regulatory review process for lab-developed tests.</p><div class=\"tiny-share-widget\" data-id=\"681081\" data-linked=\"Rosetta Genomics (ROSG-OLD +9.7%) spikes as New York grants final approval for its miRview lung...\" data-tweet=\"$ROSG-OLD - Rosetta Genomics (ROSG-OLD +9.7%) spikes as New York grants final approval for its miRview lung assay that can accurately differentiate between the four main subtypes of lung cancer using small amounts of tumor cells. With this approval, ROS... https://seekingalpha.com/news/681081?source=tweet\" data-url=\"https://seekingalpha.com/news/681081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681061\" data-ts=\"1353683496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZLC\" target=\"_blank\">ZLC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681061\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zale&#39;s (ZLC -4.4%) moves lower with the retailer&#39;s earnings miss from earlier this week still...</a></h4>Zale's (<a href='https://seekingalpha.com/symbol/ZLC' title='Zale Corporation'>ZLC</a> <font color='red'>-4.4%</font>) moves lower with the retailer's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/678931\">earnings miss</a> from earlier this week still tipping sentiment. In an <a target=\"_blank\" href=\"https://seekingalpha.com/article/1022211-zale-s-ceo-discusses-f1q-2013-results-earnings-call-transcript\">earnings conference call</a>, execs blamed part of the decline in same-store sales growth on higher employee benefit costs and the impact of Hurricane Sandy, but the slide in shares this week suggests traders aren't buying that entirely.<div class=\"tiny-share-widget\" data-id=\"681061\" data-linked=\"Zale&#39;s (ZLC -4.4%) moves lower with the retailer&#39;s earnings miss from earlier this week still...\" data-tweet=\"$ZLC - Zale&#39;s (ZLC -4.4%) moves lower with the retailer&#39;s earnings miss from earlier this week still tipping sentiment. In an earnings conference call, execs blamed part of the decline in same-store sales growth on higher employee benefit costs and the ... https://seekingalpha.com/news/681061?source=tweet\" data-url=\"https://seekingalpha.com/news/681061\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"681021\" data-ts=\"1353682675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCPI\" target=\"_blank\">RCPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/681021\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Star Scientific (STSI +10.2%) roar higher with the company&#39;s cash situation still a...</a></h4>Shares of Star Scientific (STSI <font color='green'>+10.2%</font>) roar higher with the company's <a target=\"_blank\" href=\"http://www.washingtonpost.com/business/star-scientific-exec-shareholders-investing-20m-in-firm-ceo-cuts-salary-to-1-per-month/2012/11/16/03f30e8c-2fec-11e2-af17-67abba0676e2_story.html\">cash situation</a> still a source of intense debate. A $20M capital infusion by a group of shareholders is either a finger in the dike or a rallying point depending upon a trader's point of view.<div class=\"tiny-share-widget\" data-id=\"681021\" data-linked=\"Shares of Star Scientific (STSI +10.2%) roar higher with the company&#39;s cash situation still a...\" data-tweet=\"$RCPI - Shares of Star Scientific (STSI +10.2%) roar higher with the company&#39;s cash situation still a source of intense debate. A $20M capital infusion by a group of shareholders is either a finger in the dike or a rallying point depending upon a trader... https://seekingalpha.com/news/681021?source=tweet\" data-url=\"https://seekingalpha.com/news/681021\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"680961\" data-ts=\"1353680929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNH\" target=\"_blank\">CNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/680961\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Italy&#39;s Fiat has won over the board of its U.S. tractor and construction machinery unit...</a></h4><p>Italy's Fiat has <a target=\"_blank\" href=\"http://www.reuters.com/article/2012/11/22/fiat-industrial-idUSL1E8MM0220121122\">won over</a> the board of its U.S. tractor and construction machinery unit CNH Global (NYSE:<a href=\"https://seekingalpha.com/symbol/CNH\" title=\"CNH Global N.V.\">CNH</a>) with an improved $1.5B bid that would create the world's third-largest capital goods group by sales. The new offer, which adds a ~$300M cash dividend to a previous all-share bid, would allow Fiat to buy the 12% of CNH it doesn't already own. CNH <font color=\"green\">+4.5%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"680961\" data-linked=\"Italy&#39;s Fiat has won over the board of its U.S. tractor and construction machinery unit...\" data-tweet=\"$CNH - Italy&#39;s Fiat has won over the board of its U.S. tractor and construction machinery unit CNH Global (NYSE:CNH) with an improved $1.5B bid that would create the world&#39;s third-largest capital goods group by sales. The new offer, which adds a ~$300M ... https://seekingalpha.com/news/680961?source=tweet\" data-url=\"https://seekingalpha.com/news/680961\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"680921\" data-ts=\"1353679804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/680921\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: ALU +18%. MAPP +14%. RIMM +11%. CIG +10%. SBS +7%. NBG +5%. Losers: OTC:KITD...</a></h4><b>Premarket gainers:</b> ALU <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/MAPP\" title=\"MAP Pharmaceuticals, Inc.\">MAPP</a> <font color=\"green\">+14%</font>. RIMM <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/CIG\" title=\"Companhia Energtica de Minas Gerais - CEMIG\">CIG</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/SBS\" title=\"Companhia de Saneamento Basico do Estado de Sao Paulo-SABESP\">SBS</a> <font color=\"green\">+7%</font>. NBG <font color=\"green\">+5%</font>. <br><b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/KITD\" title=\"KIT digital, Inc.\">OTC:KITD</a> <font color=\"red\">-55.56%</font>.<div class=\"tiny-share-widget\" data-id=\"680921\" data-linked=\"Premarket gainers: ALU +18%. MAPP +14%. RIMM +11%. CIG +10%. SBS +7%. NBG +5%. Losers: OTC:KITD...\" data-tweet=\"$NOK $NOK $MAPP - Premarket gainers: ALU +18%. MAPP +14%. RIMM +11%. CIG +10%. SBS +7%. NBG +5%. Losers: OTC:KITD -55.56%. https://seekingalpha.com/news/680921?source=tweet\" data-url=\"https://seekingalpha.com/news/680921\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"680911\" data-ts=\"1353679781\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCPIQ\" target=\"_blank\">MCPIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/680911\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molycorp (MCP) +4.3% premarket on news of&amp;nbsp;new insider buying; a director and a vice...</a></h4><p>Molycorp (MCP) <font color=\"green\">+4.3%</font> premarket on news of <a target=\"_blank\" href=\"http://www.streetinsider.com/Insider+Trades/Molycorp+%28MCP%29+Sees+Continued+Insider+Buying/7899883.html\">new insider buying</a>; a director and a vice president bought a combined ~55K shares at $6.20-$7.10, worth ~$400K.</p><div class=\"tiny-share-widget\" data-id=\"680911\" data-linked=\"Molycorp (MCP) +4.3% premarket on news of new insider buying; a director and a vice president...\" data-tweet=\"$MCPIQ - Molycorp (MCP) +4.3% premarket on news of new insider buying; a director and a vice president bought a combined ~55K shares at $6.20-$7.10, worth ~$400K. https://seekingalpha.com/news/680911?source=tweet\" data-url=\"https://seekingalpha.com/news/680911\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"680881\" data-ts=\"1353679089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KITD\" target=\"_blank\">KITD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/680881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KIT&amp;nbsp;Digital (OTC:KITD) -56.5% premarket after Wednesday&#39;s announced restatement of prior...</a></h4><p>KIT Digital (<a href=\"https://seekingalpha.com/symbol/KITD\" title=\"KIT digital, Inc.\">OTC:KITD</a>) <font color=\"red\">-56.5%</font> premarket after Wednesday's announced <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/680181\">restatement</a> of prior period financial statements and postponement of Q3 2012 results. This morning, KITD's former Chairman/CEO <a target=\"_blank\" href=\"http://www.ibtimes.com/press-release/20121123/former-chairman-ceo-kaleil-isaza-tuzman-sends-letter-kit-digital-board\">urges</a> the company to discuss his acquisition offer and conduct an open and transparent sale process.</p><div class=\"tiny-share-widget\" data-id=\"680881\" data-linked=\"KIT Digital (OTC:KITD) -56.5% premarket after Wednesday&#39;s announced restatement of prior period...\" data-tweet=\"$KITD - KIT Digital (OTC:KITD) -56.5% premarket after Wednesday&#39;s announced restatement of prior period financial statements and postponement of Q3 2012 results. This morning, KITD&#39;s former Chairman/CEO urges the company to discuss his acquisition offer... https://seekingalpha.com/news/680881?source=tweet\" data-url=\"https://seekingalpha.com/news/680881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"680831\" data-ts=\"1353677740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/680831\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Best Buy (NYSE:BBY) edge higher on Black Friday with the retailer trying to bounce off...</a></h4><p>Shares of Best Buy (NYSE:<a href=\"https://seekingalpha.com/symbol/BBY\" title=\"Best Buy Co.\">BBY</a>) edge higher on Black Friday with the retailer trying to bounce off of the multi-year lows they etched out after another round of <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/675961\">disappointing results</a>. Behind the scenes, the biggest focus on BBY is if founder Richard Schulze can put together a bid to buy back the firm with P-E backing. The last thought from some analysts is that the eventual deal price could creep below $20 if Schulze waits out a sluggish Q4.</p><div class=\"tiny-share-widget\" data-id=\"680831\" data-linked=\"Shares of Best Buy (NYSE:BBY) edge higher on Black Friday with the retailer trying to bounce off...\" data-tweet=\"$BBY - Shares of Best Buy (NYSE:BBY) edge higher on Black Friday with the retailer trying to bounce off of the multi-year lows they etched out after another round of disappointing results. Behind the scenes, the biggest focus on BBY is if founder Richar... https://seekingalpha.com/news/680831?source=tweet\" data-url=\"https://seekingalpha.com/news/680831\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"680761\" data-ts=\"1353674975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/680761\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Research In Motion (RIMM) jet 14.2% higher premarket, apparently fueled by enthusiasm...</a></h4><p>Shares of Research In Motion (RIMM) jet <font color=\"green\">14.2% higher</font> premarket, apparently fueled by <a target=\"_blank\" href=\"http://www.reuters.com/article/2012/11/22/us-rim-shares-idUSBRE8AL0L220121122\">enthusiasm</a> over the impending launch of Blackberry 10 devices. With the new product, National Bank's Kris Thompson now expects to ship close to 35.5M devices devices in FY14 after early estimates called for 31.6M. RIMM trades at its highest level since June.</p><div class=\"tiny-share-widget\" data-id=\"680761\" data-linked=\"Shares of Research In Motion (RIMM) jet 14.2% higher premarket, apparently fueled by enthusiasm...\" data-tweet=\"$BB - Shares of Research In Motion (RIMM) jet 14.2% higher premarket, apparently fueled by enthusiasm over the impending launch of Blackberry 10 devices. With the new product, National Bank&#39;s Kris Thompson now expects to ship close to 35.5M devices devi... https://seekingalpha.com/news/680761?source=tweet\" data-url=\"https://seekingalpha.com/news/680761\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":19,"message":null,"success":true,"today":{"start":1576645200,"end":1576731599,"str":"Wednesday, December 18, 2019"},"yesterday":{"start":1576558800,"end":1576645199}}